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Extramammary Paget's disease (EMPD) is a rare intraepidermal carcinoma and predominantly involves
apocrine gland-bearing areas, such as anogenital regions and axillae. EMPD usually involves a solitary
area and, less often, two areas in the same patient (double EMPD). The simultaneous involvement of
bilateral axillae and anogenital region, called triple extramammary Paget's disease (TEPD), is an
extremely rare subgroup of diseases that has been reported mostly from studies conducted in Japan.
Because of its rarity, the clinical course, pathology/immunohistochemical staining features, and prog-
nosis of TEPD are still unclear. Herein, to our knowledge, we present the ﬁrst case of primary invasive
TEPD with regional lymph node metastasis in Taiwan, and review the literature.
Copyright © 2016, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Extramammary Paget's disease (EMPD) is a rare intraepidermal
carcinoma that predominantly involves apocrine gland-bearing
areas such as vulva, scrotum, and perianal regions as well as
axillae. It is subdivided into primary and secondary EMPD based on
whether there is an underlying malignancy, such as adenocarci-
noma of skin appendage or noncutaneous carcinoma. The majority
of primary cases are conﬁned to the epidermis, but the incidence of
dermal invasion has been reported to be as high as 18.8%.1 Dermal
invasion is signiﬁcantly associated with lymph node metastasis,
distant metastasis, and poor prognosis.1,2
Primary triple extramammary Paget's disease (TEPD) represents
a very rare condition where the simultaneous occurrence of EMPD
is noticed over bilateral axillae and the genital region. To our
knowledge, case series of TEPD have been mostly reported in
Japan,3,4 and TEPD in other races is extremely rare.5 The clinical
course and prognosis of this rare disease are still unclear owing to
the small number of reported cases and heterogeneous entities.3,5,6
Herein, we present a case with primary invasive TEPD and reviewy have no ﬁnancial or non-
atter or materials discussed
gy, Taipei Veterans General
.
al Association. Published by Elsevithe literature. To our knowledge, this is the ﬁrst Taiwanese TEPD
case to be presented.
Case report
A 70-year-old man attended our dermatology clinic with a 6-year
history of an erythematous plaque on the left armpit and a 5-year
history of reddish plaques on bilateral groins and scrotum. He
had previously received topical antifungal agents and topical
corticosteroid for these skin lesions for 3 years in a local hospital
with poor response. Moreover, cryotherapy over whole skin lesions
every 1e3 weeks has also been given for about 1 year. Initially, the
cryotherapy showed some clinical improvement over focal skin
lesions, which healed with scaring and pigmentary change clini-
cally, but skin lesions recurred and progressed under treatment
later. During the entire treatment course, this patient did not un-
dergo any investigation for the histopathologic examination. Owing
to the progression of the disease under the aforementioned treat-
ment, he was referred to our clinic. Dermatology ﬁndings revealed
an erythematous conﬂuent erosive plaque over the base of the
penis, the left side of the scrotum, and the left inguinal area. A
residual shallow erosion was noticed over the left armpit, and an
erythematous plaque was found on the right armpit. Hyper- and
hypopigmented plaques with scarring change were noticed over
the left armpit and the right inguinal area (Figure 1). Incisional
biopsies were performed from the clinically involved areas of
bilateral armpits and left scrotum. The pathology of the righter Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 (A) The patient presented an asymptomatic, incidentally noticed erythematous plaque on right armpit; (B) a residual shallow erosion (arrowhead) with multiple hy-
perpigmentation and hypopigmentation (arrow) that was caused by repeat cryotherapy; (C) an extensive erosive plaque over pubic area was also noticed; and (D) closer view of the
plaque. Pigmentary change caused by cryotherapy was also visible over right inguinal region (arrow). Extramammary Paget's disease was histologically conﬁrmed over the three
aforementioned areas. Positive surgical margin sites in ﬁrst wide excision were demonstrated (red arrowhead) over (A) right armpit and (C) inguinal area.
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Paget's cells with pleomorphic and hyperchromatic nucleus and
pale cytoplasm. Paget's cells were immunoreactive to cytokeratin 7
(CK7) (Figure 2). The biopsy from the left armpit showed no
epidermal involvement, while displaying clustered atypical cells
with abundant pale cytoplasmwithin the ﬁbrotic dermis (Figure 3).
The atypical cells were immunoreactive to CK7, gross cystic disease
ﬂuid protein-15 (GCDFP-15), and GATA3. There was neither
palpable inguinal nor axillary lymphadenopathy. Sonography over
the breast and the left axilla did not show any abnormality. Results
of laboratory investigations were unremarkable, and tumor
markers, including carcinoembryonic antigen (CEA), were within
normal limits except for the mildly elevated prostate-speciﬁc an-
tigen (4.67 ng/mL; (normal range, 0e3 ng/mL). Routine esoph-
agogastroduodenoscopy, colonoscopy, and three sets of urineFigure 2 (A) Histopathologic examination showed typical clustered intraepidermal Page
specimens except that from ﬁrst incisional biopsy of left armpit (H&E; original magniﬁcati
original magniﬁcation,  400). H&E ¼ hematoxylin and eosin.cytology did not show any evidence of malignancy. A whole-body
positron emission tomography/computed tomography (PET/CT)
revealed no ﬂuorodeoxyglucose (FDG)-avid focus except for a small
lymph node with mildly increased FDG uptake in Level II of the
right neck, being considered with uncertain clinical signiﬁcance.
After the full cancer workup, this patient underwent wide
excision with a 3-cm margin over bilateral armpits and inguinal
area, and skin defects were repaired by split thickness skin grafts
harvested from inner thighs. Because hematoxylin and eosin
pathologic examinations showed positive surgical margins over the
lateral border of the right armpit and the lower border of the
inguinal area accompanied with dermal invasion on the inguinal
area, those two lesions were reexcised with frozen section exami-
nations. All initial frozen section samples of margins from the right
armpit were negative for tumor cells. Three frozen section samplest's cells with pleomorphic and hyperchromatic nucleus and pale cytoplasm over all
on,  100); and (B) Paget's cells were strongly immunoreactive to cytokeratin 7 (CK7;
Figure 3 Histopathologic examination of the ﬁrst incisional biopsy from left armpit. (A) Clustered atypical cells with abundant pinkish cytoplasm (arrowhead) within ﬁbrotic
dermis. There was no epidermal involvement (H&E; original magniﬁcation  40); (B) closer view of atypical cells within middle dermis (H&E, original magniﬁcation  400); (C)
atypical cells were labeled by cytokeratin 7 (CK7; original magniﬁcation  400); and (D) atypical cells were also immunosensitive to GATA3 (GATA3; original magniﬁcation  400).
H&E ¼ hematoxylin and eosin.
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fourth sampling result was negative. Lymph nodes were palpable
over the left inguinal area during the operation, and were excised
for pathologic examination because of the established evidence of
dermal invasion. Then, all wounds were covered with split thick-
ness skin grafts harvested from bilateral thighs in the second
operation, and the patient withstood the whole procedure well.
An histopathologic examination displayed typical EMPD
epidermal involvement over three sites, and one of the three lymph
nodes harvested intraoperatively, measuring 10  8  5 mm,
showedmetastasis. On immunohistochemical staining, Paget's cells
were strongly and diffusely positive for CK7 and focally positive for
GCDFP-15. Additional stains for CEA and mucicarmine were also
positive.
There was no evidence of local or distant recurrence 4 months
after the last operation. Systemic chemotherapy was suggested by
the hematologist as further adjuvant therapy.
Discussion
TEPD is a very rare subgroup among EMPDs, and only a few case
reports or case series have been published. This is the ﬁrst reported
Taiwanese case of TEPD. Most cases were reported from Japan.
There was a male predominance in the patient groups.4 Including
our case, all but one of the 29 cases were male.3e5 In most TEPD
cases, for unknown reasons, genital lesions preceded the axillary
lesions except in one Japanese case and our own case.6 The pre-
sentation of TEPD, especially axillary lesion, was variable. Some
reports in Japan showed subclinical diseases in axillae, which were
conﬁrmed by biopsies.3,4 Accordingly, some authors recommended
to carefully check for almost invisible axillary lesions, even
considering random biopsy, in patients with genital Paget's dis-
ease.4 To our knowledge, our patient is the ﬁrst case of TEPD toreceive long-term cryotherapy even before the ﬁnal diagnosis was
made. The pigmentary change and tissue scarring caused by cryo-
therapy distracted our attention initially, and fortunately we still
noticed the asymptomatic small skin lesion over the right armpit
during routine physical examination. The incidence of secondary
EMPD in Asian populations is reported to be lower than that in
Caucasian populations.1,7 Including two Caucasian cases, all cases of
TEPD reported were primary diseases.5,8
The incidence of invasive EMPD was reported as 18.8% in a
retrospective study in China, including 48 patients (all were solitary
EMPDs).1 To our knowledge, including this case, there were 12%
TEPD patients (4/33 patients) with dermal invasion. There was a
lack of solid evidence to clarify whether the severity of surface
involvement can predict the risk of dermal invasion. However,
dermal invasion had been conﬁrmed as a predictor of distant
metastasis,1,2,9 although it should be noted that themetastatic cases
were not associated with larger skin lesions.9 Adachi et al6 reported
one invasive TEPD case that presented an erythematous plaque
over the left axilla for 20 years without treatment, and this lesion
proceeded lately with an erosive tumor on the left axillary lesion,
and erythematous plaques over the right axilla and genital area.
Those three sites of lesions were pathologically conﬁrmed as EMPD,
and the erosive tumor corresponded to the invasive part.6 Similarly,
our case also had long-lasting lesions over the left axilla and genital
area, which were pathologically conﬁrmed as invasive EMPD, even
though no tumor lesion was noticed. In TEPD, further study is
necessary to clarify the relationship between the chronicity of
disease, the measurement of epidermal involvement, and the
development of invasive disease.
Whether immunohistochemistry can be a reliable tool to
differentiate primary from secondary EMPD is still debatable, and
many studies have led to inconsistent results.5,7,10 Paget's cells of
both origins are usually immunosensitive to CK7, CEA, and
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GCDFP-15 is variable.10 A review article noticed that CK20 was
found more frequently in cases of secondary EMPD, whereas
GCDFP-15 was more associated with the primary disease.10 How-
ever, only 58% of primary EMPD cases had the immunophenotype
CK20(e)/GCDFP-15(þ) reported in a Taiwanese study.7 The study of
immunophenotype in TEPD has been scanty. Among the 32 re-
ported cases of primary type, only two presented immunopheno-
type: one was positive to CK7, CEA, and estrogen and progesterone
receptors, but negative to CK20 and GCDFP-15; the other was
immunosensitive to CK7 but not CD20. As a primary TEPD, our case
was observed to be immunosensitive to CK7, GCDFP-15, CEA, and
estrogen receptor, which was consistent with previous studies.10
TEPD, regarded as a multicentric EMPD, seems to display similar
immunophenotype to solitary EMPD. The ﬁrst specimen from the
left axilla was observed to be immunoreactive to GATA3, which is
well known as a useful stain to label breast cancer cells, especially
in axillae. However, a recent study in China presented GATA3
expression in all cases of vulvar Paget's disease.11 Therefore, further
study is necessary to conﬁrm the role of GATA3 expression in
vulvar/nonvulvar EMPD. It was reasonable to survey for underlying
adenocarcinoma, especially breast cancer, in the clinical setting
where GATA3-positive cells in axillae were encountered.
PET/CT, which is proven to detect nodal involvement and distant
metastasis in many malignant tumors, seems to be a useful tool to
evaluate EMPD based on previous studies.9,12,13 PET/CT can reveal
occult nodal and distant metastasis, guide treatment plan, and
enable more accurate prognosis in cases of EMPD. However, PET/CT
was reported to have a low sensitivity for detecting metastatic
nodes smaller than 10 mm.14 Moreover, dermal invasion is proven
to be signiﬁcantly associated with regional nodal involvement and
distant metastasis, and lead to a worse prognosis. Thus, several
studies suggested that elective lymph node dissection/sentinel
lymph node biopsy should be taken as well as local wide excision in
every case of EMPD with reticular dermis or deeper invasion, and
even negative results in the PET/CT scan.2,9 Our patient, whose PET/
CT report was negative, also received lymph node dissection over
the invasive part of TEPD, and the pathology report revealed nodal
involvement, which is a marker of poor prognosis. The false-
negative result of PET/CT in our patient could be, at least
partially, ascribed to the small size of the positive lymph node (only
10  8  5 mm in size). We recommended elective lymph node
dissection accompanied with local wide excision for cases of EMPD
with deep invasion, even though the preoperative PET/CT showed
negative ﬁndings. When regional lymph nodes are involved, this
disease seems to be a systemic problem, and distant metastasis,
maybe an occult one, could be noticed soon. In a Chinese study
including six cases of penosacral EMPD and inguinal lymph node
metastasis, three cases showed occult distant lymph node
involvement in the following PET/CT scan, and the other three
patients, who only received wide excision and inguinal lympha-
denectomy, developed distant metastasis within 1 year.9 Our pa-
tient was planning to receive systemic chemotherapy as an
adjuvant therapy.
The level of dermal invasion and status of nodal/distant
metastasis were signiﬁcantly associated with decreased survival in
EMPD. However, tumor size and longest diameter of skin lesion
were not associated with poor prognosis.9,15 These results impliedthat the area of the involved skin regions alone may not lead to a
different prognosis in TEPD. Primary noninvasive TEPD was re-
ported to have a favorable outcome,4,5 but to our knowledge, aside
from our case, only three cases of invasive TEPD have been pub-
lished in the literature. Prognosis was mentioned in two cases: one
had lung metastasis in 2 years and the other one died from stroke
during admission.3,6Whether TEPD has similar a clinical course and
prognostic factors with solitary EMPD requires further evaluation.
TEPD is a rare subgroup of EMPDs, and this disease entity has
highly variable clinical presentation, especially over the axillary
area. This is the ﬁrst case of TEPD reported in Taiwan, and physi-
cians may easily be unaware of its presence during the initial
consultation. Therefore, we strongly recommend that a thorough
physical examination of every patient with EMPD be conducted,
regardless of whether it is in the pubic or axillary area, and skin
biopsy should be considered for suspicious lesions. Although the
clinical course, prognostic factors, and survival rate of TEPD still
require further studies to clarify, multifocal EMPD, level of dermal
invasion, and status of metastasis seem to be reasonable predictors
of the outcome. PET/CT is a good tool to evaluate the disease
burden, but we should be aware of its limitations. We suggest that
regional lymph node dissection be considered in every case of
invasive EMPD/TEPD, even if PET/CT shows a negative result. If
metastasis is noticed, we suggest treating this disease in a systemic
method, such as chemotherapy, when the patient can tolerate its
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